Evidence map›Paper›PMID 33720748›Full record

ArticleJCO global oncology2021

Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia as an Example.

Majed A Alghamdi, Suliman M Alghamdi, Yasir A Bahadur, Mushabbab A Asiri, Hussain A AlHussain, Adnan S Alhebshi, Majid O Alothman, Ameen S Al-Omair, Abdulaziz A Alghamdi, Ahmed S Qanat and 7 more

Abstract read
In one paragraph

Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Majed A AlghamdiDepartment of Medicine, College of Medicine, Al Baha University, Al Baha, Saudi Arabia.ORCID 0000-0003-0779-079X
Suliman M AlghamdiRadiation Oncology, Princess Norah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Yasir A BahadurDepartment of Radiology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Mushabbab A AsiriRadiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Hussain A AlHussainRadiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID 0000-0001-7533-0088
Adnan S AlhebshiRadiation Oncology, Oncology Institute, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Majid O AlothmanRadiation Oncology, Oncology Institute, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Ameen S Al-OmairRadiation Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Abdulaziz A AlghamdiCollege of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-1402-5001
Ahmed S QanatCollege of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-8952-8674
Mohammed O AqeeliCollege of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-6946-4773
Abdullah A AlsuhaibaniRadiation Oncology, University Oncology Center, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-2108-785X
Salem M AlshehriRadaition Oncology, Department of Oncology, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.ORCID 0000-0002-1122-8655
Ibrahim M AlotainRadaition Oncology, Department of Oncology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Noor K MailRadiation Oncology, Princess Norah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Hashem H AlhashemiDepartment of Internal Medicine, King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Hossam A AlassafRadiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID 0000-0002-5905-7592

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine the trends and quality metrics of publications by radiation oncologists in Saudi Arabia.

methodsPubMed was searched using names of all Saudi radiation oncologists to retrieve published articles between January 2010 and December 2019. International collaboration, journal impact factor and country of origin, and number of citations were collected. Each article was assessed for epidemiologic type and independently assigned a level of evidence (LOE) by two authors. The trend in publications was examined and compared in the first and second 5-year periods (2010-2014 and 2015-2019) using relevant parameters.

resultsA total of 186 publications were found and included. The most common type of research was cohort studies followed by case reports and case series in 24%, 14%, and 13% of all publications, respectively. Dosimetry, clinical, and preclinical studies formed 7%, 8.6%, and 7.5% of the total publications, respectively. The LOE was I, II, III, IV, and not applicable in 8.6%, 22%, 25.8%, 29%, and 14.5% of the included publications, respectively. Comparing the first and second 5-year periods, there was an increase in international collaboration (

conclusionAlthough radiation oncology research activity in Saudi Arabia has gained momentum in terms of volume and international collaboration over time, the LOE has not improved. This calls for a national effort to make the contribution to the literature a priority, allocate adequate resources, and apply appropriate measures to enhance research productivity and quality.

Indexed as

Biomedical ResearchRadiation OncologistsDeveloping CountriesHumansPublicationsSaudi Arabia

Identifiers

PMID33720748
PMCPMC8081503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.